About CardieX
CardieX is a company based in Sydney (Australia) founded in 1994.. CardieX has completed 1 acquisition, including Blumio. CardieX offers products and services including SphygmoCor XCEL, CONNEQT Pulse, and Oscar 2. CardieX operates in a competitive market with competitors including AliveCor, iRhythm Tech, Imperative Care, Aktiia and ZOLL AEDs, among others.
- Headquarter Sydney, Australia
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cardiex Limited
-
Annual Revenue
$2.35 M (USD)-67.44as on Jun 30, 2025
-
Net Profit
$-8.74 M (USD)-95.49as on Jun 30, 2025
-
EBITDA
$-9.59 M (USD)-129.78as on Jun 30, 2025
-
Latest Funding Round
$4.5 M (USD), Post-IPO
Aug 22, 2022
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CardieX
CardieX is a publicly listed company on the ASX with ticker symbol CDX in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CardieX
CardieX offers a comprehensive portfolio of products and services, including SphygmoCor XCEL, CONNEQT Pulse, and Oscar 2. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Noninvasive tool for assessing arterial and cardiovascular health.
Platform for cardiovascular health data and remote monitoring.
Device for tracking blood pressure and vascular health metrics.
Unlock access to complete
Unlock access to complete
Funding Insights of CardieX
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $4.5M
-
First Round
First Round
(22 Aug 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Post-IPO - CardieX | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CardieX
CardieX has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C2 Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by C2 Ventures in early-stage tech startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CardieX
CardieX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Blumio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contactless blood pressure monitor
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - CardieX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cardiex Comparisons
Competitors of CardieX
CardieX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AliveCor, iRhythm Tech, Imperative Care, Aktiia and ZOLL AEDs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| domain | founded_year | HQ Location |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Access catheters for neurovascular stroke treatment are provided.
|
|
| domain | founded_year | HQ Location |
Offers wearable technology for 24/7 blood pressure tracking and app-based data analysis.
|
|
| domain | founded_year | HQ Location |
Medical devices and software for emergency care are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cardiex
Frequently Asked Questions about CardieX
When was CardieX founded?
CardieX was founded in 1994 and raised its 1st funding round 28 years after it was founded.
Where is CardieX located?
CardieX is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
What is the annual revenue of CardieX?
Annual revenue of CardieX is $2.35M as on Jun 30, 2025.
What does CardieX do?
CardieX was founded in 1994 in Sydney, Australia, and operates in the cardiac health sector. Digital and device-based solutions are offered, including an FDA-approved device for measuring blood pressure and cardiovascular risk parameters. The AtCor medical device is provided for detecting target organ damage and managing cardiovascular and renal diseases. Wearable smart devices are also supplied to identify risks for hypertension, cardiovascular disease, and kidney-related conditions.
Who are the top competitors of CardieX?
CardieX's top competitors include AliveCor, iRhythm Tech and Imperative Care.
What products or services does CardieX offer?
CardieX offers SphygmoCor XCEL, CONNEQT Pulse, and Oscar 2.
Is CardieX publicly traded?
Yes, CardieX is publicly traded on ASX under the ticker symbol CDX.
How many acquisitions has CardieX made?
CardieX has made 1 acquisition, including Blumio.
Who are CardieX's investors?
CardieX has 1 investor. Key investors include C2 Ventures.
What is CardieX's ticker symbol?
The ticker symbol of CardieX is CDX on ASX.